Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
Hirofumi KuwabaraAkira ToriiharaKeiko Yuasa-NakagawaKazuma TodaUkihide TateishiRyoichi YoshimuraPublished in: Head & neck (2018)
Not the percent change but the value calculated in the early phase in several parameters using dual-time-point FDG-PET/CT is significantly associated with the outcomes of patients with locally advanced oropharyngeal or hypopharyngeal cancer.
Keyphrases
- positron emission tomography
- computed tomography
- papillary thyroid
- locally advanced
- pet ct
- squamous cell
- pet imaging
- squamous cell carcinoma
- rectal cancer
- magnetic resonance imaging
- neoadjuvant chemotherapy
- lymph node metastasis
- radiation therapy
- image quality
- clinical trial
- type diabetes
- dual energy
- skeletal muscle
- weight loss
- young adults
- open label
- phase ii study